In the last trading session, 0.25 million Outset Medical Inc (NASDAQ:OM) shares changed hands as the company’s beta touched 2.08. With the company’s per share price at $1.13 changed hands at -$0.05 or -4.24% during last session, the market valuation stood at $61.47M. OM’s last price was a discount, traded about -420.35% off its 52-week high of $5.88. The share price had its 52-week low at $0.44, which suggests the last value was 61.06% up since then. When we look at Outset Medical Inc’s average trading volume, we note the 10-day average is 0.6 million shares, with the 3-month average coming to 787.59K.

Analysts gave the Outset Medical Inc (OM) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.80. If we narrow down to specifics, the data shows that 0 out of 8 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 2 recommended OM as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight. Outset Medical Inc’s EPS for the current quarter is expected to be -0.41.

Outset Medical Inc (NASDAQ:OM) trade information

Instantly OM was in red as seen at the end of in last trading. With action 15.84%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -78.37%, with the 5-day performance at 15.84% in the green. However, in the 30-day time frame, Outset Medical Inc (NASDAQ:OM) is 39.68% up. Looking at the short shares, we see there were 2.8 million shares sold at short interest cover period of 2.94 days.

The consensus price target for the stock as assigned by Wall Street analysts is 3, meaning bulls need an upside of 62.33% from its current market value. According to analyst projections, OM’s forecast low is 3 with 3 as the target high. To hit the forecast high, the stock’s price needs a -165.49% plunge from its current level, while the stock would need to soar -165.49% for it to hit the projected low.

Outset Medical Inc (OM) estimates and forecasts

Data shows that the Outset Medical Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -71.04% over the past 6 months, a 30.74% in annual growth rate that is considerably higher than the industry average of 24.80%. Year-over-year growth is forecast to reach -13.79% down from the last financial year.

Consensus estimates given by 5 financial analysts project the company’s revenue in the current quarter to hit an average of 27.85M. 4 analysts are of the opinion that Outset Medical Inc’s revenue for the current quarter will be 29.58M. The company’s revenue for the corresponding quarters a year ago was 30.5M and 28.17M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -8.68%. The estimates for the next quarter sales put growth at 5.01%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -15.08%. The 2024 estimates are for Outset Medical Inc earnings to increase by 25.83%, but the outlook for the next 5-year period is at 23.80% per year.

OM Dividends

Outset Medical Inc is expected to release its next quarterly earnings report in January.

Outset Medical Inc (NASDAQ:OM)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 2.11% of Outset Medical Inc shares while 52.16% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 53.28%. There are 52.16% institutions holding the Outset Medical Inc stock share, with FMR LLC the top institutional holder. As of 2024-06-30, the company held 15.1214% of the shares, roughly 7.7 million OM shares worth $29.63 million.

AMERIPRISE FINANCIAL INC holds the second largest percentage of outstanding shares, with 10.2162% or 5.2 million shares worth $20.02 million as of 2024-06-30.